rheumatoid arthritis
The combination of sulfasalazine, methotrexate with reducing       high-dose prednisolone, is demonstrated to be cost-effective in patients with       rheumatoid arthritis, but although several other combinations have been reported        effective in patients with rheumatoid arthritis, most trials do not have the       power to provide a definitive answer as to the best combination available, if one       exists.
The combination of sulfasalazine, methotrexate with reducing       high-dose prednisolone, is demonstrated to be cost-effective in patients with       rheumatoid arthritis, but although several other combinations have been reported        effective in  @OBJECT$   @PREDICAT$   @SUBJECT$ , most trials do not have the       power to provide a definitive answer as to the best combination available, if one       exists.